Raymond James & Associates Evolent Health, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Evolent Health, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 17,598 shares of EVH stock, worth $73,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,598
Previous 17,349
1.44%
Holding current value
$73,559
Previous $331,000
50.15%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding EVH
# of Institutions
275Shares Held
130MCall Options Held
322KPut Options Held
211K-
Cadian Capital Management, LP New York, NY11.7MShares$49 Million5.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$45.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.69MShares$36.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY7.98MShares$33.4 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.29MShares$26.3 Million0.98% of portfolio
About Evolent Health, Inc.
- Ticker EVH
- Exchange NYSE
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 97,063,696
- Market Cap $406M
- Description
- Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...